RMD Q3 2023 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q3 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.1B+29.2% YoY

Gross Profit

$618M55.3% margin

Operating Income

$301M26.9% margin

Net Income

$233M20.8% margin

EPS (Diluted)

$1.58

QoQ Revenue Growth

+8.0%

Cash Flow

Operating Cash Flow

$283M

Free Cash Flow

$251M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$6.7B

Total Liabilities

$2.8B

Stockholders' Equity

$3.9B

Cash & Equivalents

$228M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$865M	+29.2%
Gross Profit	$618M	$491M	+25.8%
Operating Income	$301M	$234M	+28.3%
Net Income	$233M	$179M	+29.9%

Revenue Segments

Sleep And Respiratory

$980M88%

Software As Service

$137M12%

Geographic Segments

Us Canada And Latin America

$629M56%

Combined Europe Asia And Other Markets

$351M31%

Software As Service

$137M12%